Clinical trial
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases…
NCT00138983 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00138983 |
|---|---|
| Title | Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. |
| Official title | Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol. |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Dutch Health Care Insurance Board |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis, Polymyalgia Rheumatica, Giant Cell Arteritis, Polymyositis, Wegener's Granulomatosis |
| Intervention type | Drug |
| Interventions | Alendronate versus alfacalcidol (1-alpha OH vitamin D) |
| Enrollment | 200 |
| Start date | May 1, 2000 |
| Completion | Nov 1, 2003 |
| First posted | Aug 30, 2005 |
| Last update posted | Nov 29, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: